KOD

Kodiak Sciences Inc

6.00 USD
-0.01 (-0.17%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Kodiak Sciences Inc stock is up 48.88% since 30 days ago. The next earnings date is Mar 26, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 5 March’s closed higher than February.

About Kodiak Sciences Inc

Kodiak Sciences Inc. researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD) The company was formerly known as Oligasis, LLC.